Shanghai, China · Founded 2013 · Privately Held (backing)
Developer of gene editing and cell engineering platforms intended for genetic and immune-related disorders. BRL Medicine is based in Shanghai, China and was founded in 2013. It has raised $55.6 million.
Last price · $/share
—
Implied valuation
—
Total raised
$55.6M
Last round
—
Team — not yet on record
No current team members for BRL Medicine are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BRL Medicine with a free account
·The complete investor list: 14 names
·Watch BRL Medicine: the Monday email on marks, rounds and moves
